RE:Melton off to VertexBioTeck wrote: https://www.biospace.com/article/harvard-researcher-heads-to-vertex-to-curate-diabetes-portfolio/
Bringing in an expensive pinch hitter doesn't guarantee you a world series title.
Melton will be just as constrained as Witkowski by all the protocols, safety concerns, finding patients etc. This will be a slow crawl (whether partnered or separately) to the finish line, not a mad dash. Vertex published "positive" 90 day data for their 1st patient in October last year. The results were called "unprecedented" and "truly remarkable". Okay, so they own a better thesaurus than SVA and have a ton of money (one billion for Semma). But it's still a phase1/2 study with
2028 being the completion date. Do I want Dr. T to sell out for a three dollar bill? Not really.
https://clinicaltrials.gov/ct2/show/NCT04786262?term=VX-880&draw=2&rank=1